News / Stock

Spain: Biopharma, Grifols Invests in Human Plasma. According To Alphie The Stock Is Bullish.

May 22, 2020 - 14:06 GMT+0000

The company operates production facilities in Spain, the US, Mexico and Australia. Grifols (GRLS.MC), listed at the Madrid stock exchange in Euros, is a company engage din the manufacture of biopharmaceuticals. The company’s Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood ranks. According to an internal report, the company’s revenue for 2019 totaled 5.09 billion Euros. The company’s stock price has been gradually decreasing since late April and can now be found at 30.1…

Register to continue reading for free